Correction to: Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU | springermedizin.de

Springer Medizin

nach oben

Clinical Drug Investigation

Erschienen in:

01.02.2019 | Correction

Correction to: Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU

verfasst von: Sohita Dhillon

Erschienen in: Clinical Drug Investigation | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Excerpt

An Online First version of this article was made available online at https://rd.springer.com/article/10.1007%2Fs40261-018-0741-2 on 3 January 2019. An error was subsequently identified in the article, and the following correction should be noted: …

Anzeige

Titel: Correction to: Neratinib in Early-Stage Breast Cancer: A Profile of Its Use in the EU
verfasst von: Sohita Dhillon
Publikationsdatum: 01.02.2019
Verlag: Springer International Publishing
Erschienen in: Clinical Drug Investigation / Ausgabe 2/2019
Print ISSN: 1173-2563
Elektronische ISSN: 1179-1918
DOI: https://doi.org/10.1007/s40261-019-00758-9